Breaking News

Molecular Profiles Appoints Head of U.S. Sales

May 13, 2014

Aims to expand presence in North American market

Charles D. Maher has been appointed head of U.S. sales at Molecular Profiles to expand the company’s client base in the U.S. for its pharmaceutical development services. He will focus on technologies with advanced characterization, formulation development and manufacturing.The company also recently invested in GMP hot melt extrusion (HME) technology for processing of difficult-to-progress molecules.   
Mr. Maher has extensive senior commercial experience in the global contract services market. Most recently he served as vice president of Business Global Development, U.S. and Europe for an international pharmaceutical R&D services company. 
Dr. Nikin Patel, chief executive officer at Molecular Profiles, said, “Over the years, we have built a solid reputation in Europe for applying a science driven approach to our clients’ development challenges in a cost-effective manner that delivers value by accelerating development. We are now striding toward executing our strategy to replicate this success in the U.S.
“I am delighted to welcome Charles to the company. His extensive knowledge of the market, experience and strong industry contacts should benefit our efforts to capitalize on our state-of-the-art facility, manufacturing capabilities and growing suite of enabling technologies among pharmaceutical and biotech companies.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important